Crowdonomics
All companies
Conexeu Sciences Inc. logo

Conexeu Sciences Inc.

Operating

Reno, NV

Visit website
Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$308,592
Across 1 round since 2025
Latest share price
$2.00
Reg CF Offering (2025) offering price

Financials

FY2023–FY2025 · from SEC filings · hover any figure for its source
$0
−$36K
2023
$0
−$472K
2024
$0
−$3.9M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2023
FY2024
FY2025
Income statement
Revenue
$0
$0
$0
Cost of goods sold
$0
$0
$0
Net income
-$35,697
-$471,867
-$3,923,557
Taxes paid
$0
$0
$0
Balance sheet
Cash
$0
$314,616
$4,808,965
Accounts receivable
$0
$0
$0
Total assets
$0
$533,940
$7,688,711
Short-term debt
$4,275
$7,912
$3,722
Long-term debt
$0
$98,117
$0
Total liabilities
$4,275
$106,029
$3,722
Other
Headcount
—
0
5

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Reg CF Offering (2025)ClosedReg CF · Common Equity · via Private
Raised $308.6K / $5M

Team

3 people
/s/ Jeff Sharpe
Chief Executive Officer and Director
/s/ Brian Pilcher
President, Chief Medical Officer and Director
/s/ Stephen Inouye
Chief Financial Officer, Secretary, Treasurer

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Compliant

Filed 1 of 1 annual reports (FY2025)

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARMar 2, 20260001062993-26-001214
    EDGAR
  • Form C-UOct 14, 20250001062993-25-016029
    EDGAR
  • Form C-USep 23, 20250001062993-25-015759
    EDGAR
  • Form CJul 30, 20250001062993-25-013275
    EDGAR
  • Form C/AJul 30, 20250001062993-25-013287
    EDGAR
Source: SEC EDGARCIK 0002066836NVShare price $2.00Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.